ResultsIQ

ResultsIQ › Latest results › Vimta Labs Limited

Vimta Labs Limited Q2 FY26 results deck summary

NSE: VIMTALABS · BSE: 524394

Results deck of 3 Nov 2025, summarised by AI from the filing.

Q2 FY26 total income ₹1,045 mn, up 22.3% YoY, with EBITDA margin 35.3% and PAT margin 19.1%.

Key takeaways

  1. H1 result H1 FY26 total income ₹2,038 mn (H1 FY25: ₹1,610 mn, +26.6% YoY); EBITDA ₹723 mn, margin 35.5%; PAT ₹388 mn, margin 19.0%.
  2. QoQ change Total income rose to ₹1,045 mn in Q2 FY26 from ₹993 mn in Q1 FY26, up 5.2% QoQ.
  3. Risk Forward-looking statements are subject to risks and uncertainties that could cause actual outcomes to differ materially.

Original filing on BSE

Vimta Labs Limited Q1 FY27 results

As filed: Revenue ₹109 cr (+11% year on year), EBITDA ₹37.3 cr (+13% year on year), PAT ₹21.0 cr (+11% year on year), EBITDA margin 34.2% (+54 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹109 cr (+16% year on year), EBITDA ₹39.4 cr (+23% year on year), PAT ₹21.1 cr (+17% year on year), EBITDA margin 36.0% (+199 bps). Score 50 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was in line with it; profit growth was below it. EBITDA margin rose 199 bps year on year. Share price after the results: +6.6% in 30 days (Nifty 500: −2.9%).
  • Q3 FY26: Revenue ₹98.6 cr (+11% year on year), EBITDA ₹34.2 cr (+4% year on year), PAT ₹17.6 cr (−16% year on year), EBITDA margin 34.7% (−236 bps). Score 35 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it; profit growth was well below it. EBITDA margin fell 236 bps year on year. Revenue fell 3% from last quarter. Revenue rose ₹9.6 cr on a year ago, more than the ₹9.0 cr it added the year before. Share price after the results: −15.3% in 30 days (Nifty 500: +2.5%).
  • Q2 FY26: Revenue ₹102 cr (+23% year on year), EBITDA ₹33.0 cr (+18% year on year), PAT ₹20.0 cr (+33% year on year), EBITDA margin 32.4% (−138 bps). Score 52 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 138 bps year on year. Revenue rose ₹19.0 cr on a year ago, more than the ₹11.0 cr it added the year before. Share price after the results: −7.4% in 30 days (Nifty 500: +0.6%).
  • Q1 FY26: Revenue ₹98.0 cr (+23% year on year), EBITDA ₹33.0 cr (+43% year on year), PAT ₹19.0 cr (+58% year on year), EBITDA margin 33.7% (+492 bps). Score 66 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit growth was in line with it. EBITDA margin rose 492 bps year on year. Share price after the results: +39.4% in 28 days (Nifty 500: −3.4%).
  • Q4 FY25: Revenue ₹94.0 cr (+21% year on year), EBITDA ₹32.0 cr (+28% year on year), PAT ₹18.0 cr (+50% year on year), EBITDA margin 34.0% (+199 bps). Score 65 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin rose 199 bps year on year. Profit fell 14% from last quarter. Share price after the results: −4.5% in 30 days (Nifty 500: +3.1%).
  • Q3 FY25: Revenue ₹90.0 cr (+10% year on year), EBITDA ₹34.0 cr (+48% year on year), PAT ₹22.0 cr (+120% year on year), EBITDA margin 37.8% (+973 bps). Score 70 of 100, Above trend. Revenue and EBITDA growth were above the company's own trend; profit growth was well above it. EBITDA margin rose 973 bps year on year.
  • Q2 FY25: Revenue ₹85.0 cr (+16% year on year), EBITDA ₹29.0 cr (+81% year on year), PAT ₹15.0 cr (+150% year on year), EBITDA margin 34.1% (+1,000 bps). Score 87 of 100, Above trend. EBITDA margin rose 1000 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Vimta Labs Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.